These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Nephrology 2009]. Zidek W Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1316-8. PubMed ID: 19517322 [No Abstract] [Full Text] [Related]
3. [Clinical study on nephrology]. Imai E; Hamano T Nihon Jinzo Gakkai Shi; 2010; 52(1):13-27. PubMed ID: 20166535 [No Abstract] [Full Text] [Related]
4. The CARI guidelines. Prevention of progression of kidney disease. Harris D; Thomas M; Johnson D; Nicholls K; Gillin A; Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S2-197. PubMed ID: 16684077 [No Abstract] [Full Text] [Related]
5. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L; Kocks MJ; Laverman GD; Navis G Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [TBL] [Abstract][Full Text] [Related]
6. [ACE inhibitors and AT-II antagonists--do they protect against renal disease?]. Rossing P; Parving HH Ugeskr Laeger; 2006 Apr; 168(15):1564; author reply1564-5. PubMed ID: 16640990 [No Abstract] [Full Text] [Related]
7. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease. Cantarovich F; Rangoonwala B Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572 [TBL] [Abstract][Full Text] [Related]
8. [Microinflammation in the pathogenesis of diabetic nephropathy]. Shikata K Nihon Jinzo Gakkai Shi; 2007; 49(5):474-80. PubMed ID: 17695807 [No Abstract] [Full Text] [Related]
9. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists]. Tesar V Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169 [TBL] [Abstract][Full Text] [Related]
10. Slowing progression along the renal disease continuum. Kopyt NP J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338 [TBL] [Abstract][Full Text] [Related]
11. The road to renal failure: an overview of diabetic nephropathy. McCrary EB Adv Nurse Pract; 2008 Jul; 16(7):61-3. PubMed ID: 19181161 [No Abstract] [Full Text] [Related]
12. Progression of chronic kidney disease: can it be prevented or arrested? Jaber BL; Madias NE Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-receptor blockade in renal disease: the hard issues. Sica DA Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):469-71. PubMed ID: 15225107 [No Abstract] [Full Text] [Related]
14. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors. Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817 [TBL] [Abstract][Full Text] [Related]
15. [Historical remarks on nephrology research in Japan: Clinical research on renal failure (discussion)]. Maeda T; Inoo T; Shibata M; Takamitsu Y Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):405-29. PubMed ID: 14509217 [No Abstract] [Full Text] [Related]
16. Update in nephrology. Maher MJ; Dworkin LD Med Health R I; 1996 Mar; 79(3):110-12. PubMed ID: 8901292 [No Abstract] [Full Text] [Related]
17. Importance of modulating the renin-angiotensin system in preventing renal complications of hypertension. Rayner B Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):469-80. PubMed ID: 17186680 [TBL] [Abstract][Full Text] [Related]
18. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be? Hollenberg NK; Epstein M Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325 [No Abstract] [Full Text] [Related]